{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2026-01-30T12:33:21.905380+00:00",
  "news": [
    {
      "title": "Prediction: 2026 Will Be the Year of Vertex Pharmaceuticals - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPZG5FX0otdUtWQXFNcVJHS2FaUnRjNFNmbHB6NURFN1pBdUxlZllFMmFaeE93U3FUSF9kT0RxS0ZWMzFrMnFmUnVvNS1XX2VRVjEwTHpYUUNidXVYZjktZ2RrRlhRWUpQTUgyWklsV1BIemJNNkh6dlBsdC0yYUluRDBBeFdIX1RtNjBOS1Vhb3RwU3JRWEJ4MA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxPZG5FX0otdUtWQXFNcVJHS2FaUnRjNFNmbHB6NURFN1pBdUxlZllFMmFaeE93U3FUSF9kT0RxS0ZWMzFrMnFmUnVvNS1XX2VRVjEwTHpYUUNidXVYZjktZ2RrRlhRWUpQTUgyWklsV1BIemJNNkh6dlBsdC0yYUluRDBBeFdIX1RtNjBOS1Vhb3RwU3JRWEJ4MA?oc=5\" target=\"_blank\">Prediction: 2026 Will Be the Year of Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2026-01-29T14:00:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Assessing Vertex Pharmaceuticals (VRTX) Valuation After Fund Exit And Setback For Journavx Pain Label - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Assessing Vertex Pharmaceuticals (VRTX) Valuation After Fund Exit And Setback For Journavx Pain Label</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2026-01-29T15:38:54+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "What's Driving the Market Sentiment Around Vertex Pharmaceuticals Inc? - Benzinga",
      "link": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOandrUU50Q2gyUm5lSFdkanlXaHVvdnJia2YxQ2VRTTZZeDNBczNBRmdyeHBHcjFuajVvZVpfaXUxYXBCMkYyeXFCLVpmNWY5NW54Y3RBMVYzM2tvQ1BxZFp2UnFibEZXZWtIZVZOT2x4Sm9ZMFBISHotMVRFblhqeU5ZZGdhbzg0bjgwZXpzbjRoWTk0bGg0UEJ3RndzTjczYUhaQ0ttOHNidi0tUVVBVWswOGZNRm1KWkc4V3pEV0VtRlJNaHpCM3hhNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiywFBVV95cUxOandrUU50Q2gyUm5lSFdkanlXaHVvdnJia2YxQ2VRTTZZeDNBczNBRmdyeHBHcjFuajVvZVpfaXUxYXBCMkYyeXFCLVpmNWY5NW54Y3RBMVYzM2tvQ1BxZFp2UnFibEZXZWtIZVZOT2x4Sm9ZMFBISHotMVRFblhqeU5ZZGdhbzg0bjgwZXpzbjRoWTk0bGg0UEJ3RndzTjczYUhaQ0ttOHNidi0tUVVBVWswOGZNRm1KWkc4V3pEV0VtRlJNaHpCM3hhNA?oc=5\" target=\"_blank\">What's Driving the Market Sentiment Around Vertex Pharmaceuticals Inc?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>",
      "published": "2026-01-29T16:00:39+00:00",
      "source": "Benzinga"
    },
    {
      "title": "Does Vertex Pharmaceuticals (VRTX) Share Price Reflect Its Long Term Growth Potential? - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPWDRSd0xMTFdtYWxxNlRxUkRpMzNTTndHNlVRSFdZN0FhakJ4dFZVNk9zenQ4MW5UZzkySHVESTR5RFpyVFZBRjZ6SnpfQm94SjdTby1jaVo1LUFFczFuS3M1dU5ua240NEdLR0hvX3Zhd1VJa19rTE5uSGJiYTRDLTJWNWtkV3NsMV9qag?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijAFBVV95cUxPWDRSd0xMTFdtYWxxNlRxUkRpMzNTTndHNlVRSFdZN0FhakJ4dFZVNk9zenQ4MW5UZzkySHVESTR5RFpyVFZBRjZ6SnpfQm94SjdTby1jaVo1LUFFczFuS3M1dU5ua240NEdLR0hvX3Zhd1VJa19rTE5uSGJiYTRDLTJWNWtkV3NsMV9qag?oc=5\" target=\"_blank\">Does Vertex Pharmaceuticals (VRTX) Share Price Reflect Its Long Term Growth Potential?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2026-01-09T08:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Presents a Compelling Value Case - Chartmill",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQTG5tNFFvWTdNUmFoNVg5ZkMza0FBbE1WcjBscmlhbEtZM1RQQWZPU3JjU1M3N1ZKWTFnNURFaVQ2bmtGU19kWjNQLUlndUxqWmdiWXExd2I0Wm1tZkdhRlpwVGR5dWtSNXlsZFpUbW4yLWVFT2tLYWRpS1hxM08tS2tDX0ZSckg3Ti0wYXpfeFJsLUk2bVJqYWtZVWM1a0JCa3hDbGVwR3Nabk10ajFEZThYS3RCcGhZWnFCUkVaOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxQTG5tNFFvWTdNUmFoNVg5ZkMza0FBbE1WcjBscmlhbEtZM1RQQWZPU3JjU1M3N1ZKWTFnNURFaVQ2bmtGU19kWjNQLUlndUxqWmdiWXExd2I0Wm1tZkdhRlpwVGR5dWtSNXlsZFpUbW4yLWVFT2tLYWRpS1hxM08tS2tDX0ZSckg3Ti0wYXpfeFJsLUk2bVJqYWtZVWM1a0JCa3hDbGVwR3Nabk10ajFEZThYS3RCcGhZWnFCUkVaOA?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Presents a Compelling Value Case</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Chartmill</font>",
      "published": "2026-01-29T12:51:46+00:00",
      "source": "Chartmill"
    },
    {
      "title": "Barclays Upgrades Vertex Pharmaceuticals (VRTX) - Nasdaq",
      "link": "https://news.google.com/rss/articles/CBMigwFBVV95cUxPbUtGZ1F5RnNPTi1abjV4SkVZMGZGMzFBTS0yTVFseVh1WmNBV3VNTkVTZHJXN29ZMlMyZUkxd1Fvdk82Ry0yQ2s3WGZiUXFzTWo0eEd1cHdjOWNQbXRVZzA2R2k4YWxhWGpMcUNZY29BV292QUlMQUc3dnVtdUllNHVDQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxPbUtGZ1F5RnNPTi1abjV4SkVZMGZGMzFBTS0yTVFseVh1WmNBV3VNTkVTZHJXN29ZMlMyZUkxd1Fvdk82Ry0yQ2s3WGZiUXFzTWo0eEd1cHdjOWNQbXRVZzA2R2k4YWxhWGpMcUNZY29BV292QUlMQUc3dnVtdUllNHVDQQ?oc=5\" target=\"_blank\">Barclays Upgrades Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
      "published": "2026-01-29T00:03:00+00:00",
      "source": "Nasdaq"
    },
    {
      "title": "Responsibility | Grants and Giving - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPempkZnJfemR2dHhGT3ZsRkJ0UDdUZ0pUUURUczhJS0I3N1JMVS04YmpRNGF0UXA2dmxFVF9seXZXRlFBUW5ZUmNZX0pGNHQ4VGFIMFFvSFhNX3VaUHA1Rm44T2pLbUctMDV6LWdXeHlzaWV4cHRIXzlvSjVwM3VkaVdxTnZKemluVC1KZUhrUHQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAFBVV95cUxPempkZnJfemR2dHhGT3ZsRkJ0UDdUZ0pUUURUczhJS0I3N1JMVS04YmpRNGF0UXA2dmxFVF9seXZXRlFBUW5ZUmNZX0pGNHQ4VGFIMFFvSFhNX3VaUHA1Rm44T2pLbUctMDV6LWdXeHlzaWV4cHRIXzlvSjVwM3VkaVdxTnZKemluVC1KZUhrUHQ?oc=5\" target=\"_blank\">Responsibility | Grants and Giving</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2026-01-21T19:40:49+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "Barclays Upgrades Vertex Pharmaceuticals (VRTX) with Increased P - GuruFocus",
      "link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOZVNnanBkMzVVS0k2OWJobVY5anZJdnlfR0xuUVlGbDFqOHJRMFlrY2tRUDFnc3Z1RmJJYjdxTlVWZVdkRWo1bm5CMDV3MkJFekRFQ2hKUHRUM0hRYk1HcGo2UWdHYlJTQU9Tc2cxMEd6RDRnY1Y5QmhjVlNkbTUwQWlfWjhmOHFJcVYwVS1Mb1dHUThka1Y4QTQzMnI0S291X2VBRTQ1UTBBUXpXVGN0N3BXcE9BRmkzeVpyVHF1SWFSQnpDTUs4?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMixwFBVV95cUxOZVNnanBkMzVVS0k2OWJobVY5anZJdnlfR0xuUVlGbDFqOHJRMFlrY2tRUDFnc3Z1RmJJYjdxTlVWZVdkRWo1bm5CMDV3MkJFekRFQ2hKUHRUM0hRYk1HcGo2UWdHYlJTQU9Tc2cxMEd6RDRnY1Y5QmhjVlNkbTUwQWlfWjhmOHFJcVYwVS1Mb1dHUThka1Y4QTQzMnI0S291X2VBRTQ1UTBBUXpXVGN0N3BXcE9BRmkzeVpyVHF1SWFSQnpDTUs4?oc=5\" target=\"_blank\">Barclays Upgrades Vertex Pharmaceuticals (VRTX) with Increased P</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GuruFocus</font>",
      "published": "2026-01-28T16:00:21+00:00",
      "source": "GuruFocus"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Vertex shares slide on reliance on old product - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOMWJTV1ZBcmtDVXRMdFluMkUzaUhGSkZhUlk2cWJtRzNaTk5uS0YwYnZkQkFGT3NsbGtSRnJYZkpWMU55dWw4NDMzMXoyLTF3a0dPWXNsczF6Q1IwSTY3ZkpBOFMzV25pNGlIN3RlNDNBcjhYbXgxREM0V2l4UzZoUE9CWGJ5TVk1Z0EwNEtnZTViSDhJ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilAFBVV95cUxOMWJTV1ZBcmtDVXRMdFluMkUzaUhGSkZhUlk2cWJtRzNaTk5uS0YwYnZkQkFGT3NsbGtSRnJYZkpWMU55dWw4NDMzMXoyLTF3a0dPWXNsczF6Q1IwSTY3ZkpBOFMzV25pNGlIN3RlNDNBcjhYbXgxREM0V2l4UzZoUE9CWGJ5TVk1Z0EwNEtnZTViSDhJ?oc=5\" target=\"_blank\">Vertex shares slide on reliance on old product</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "Vertex’s New Products Dim as Analysts Eye Kidney Portfolio - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5\" target=\"_blank\">Vertex’s New Products Dim as Analysts Eye Kidney Portfolio</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "TIKR.com"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2026-01-29",
      "close": 475.67999267578125
    },
    "history": [
      {
        "date": "2026-01-21",
        "close": 461.1400146484375
      },
      {
        "date": "2026-01-22",
        "close": 467.3500061035156
      },
      {
        "date": "2026-01-23",
        "close": 468.4100036621094
      },
      {
        "date": "2026-01-26",
        "close": 476.8399963378906
      },
      {
        "date": "2026-01-27",
        "close": 474.1700134277344
      },
      {
        "date": "2026-01-28",
        "close": 477.9100036621094
      },
      {
        "date": "2026-01-29",
        "close": 475.67999267578125
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}